PLASMA LEVELS OF HEPARANASE AS A MARKER OF TUMOR PROGRESSION AND AGGRESSIVENESS IN PATIENTS WITH COLORECTAL AND BREAST CANCER

被引：0
|
作者：
Kuten, J. [1 ]
Haim, N. [2 ]
Epelbaum, R. [1 ]
Fried, G. [1 ]
Ben Itzhak, O. [3 ]
Danus, S. [1 ]
Shaft, I. [3 ]
Vlodavsky, I. [3 ]
机构：
[1] Rambam Med Ctr, Haifa, Israel
[2] Rambam Hlth Care Campus, Oncol, Haifa, Israel
[3] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [31] Plasma and tumor expression levels of progranulin osteopontin & matrix metalloproteinase 2 in colorectal cancer patients and assessment of plasma levels for diagnosis
    Mudiyanselage, Chandana S. K. Herath
    Yan, Xiaohong
    Mitra, Neil
    Angammana, Hansani N.
    Miyagaki, Hiromichi
    Yanni, Yanni
    Cekic, Vesna
    Martz, Joseph
    Whelan, Richard L.
    CANCER RESEARCH, 2023, 83 (07)
  • [32] CLINICAL CORRELATIONS WITH TUMOR ASSOCIATED MARKER LEVELS IN BREAST-CANCER
    TORMEY, D
    WAALKES, P
    AHMANN, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 243 - 243
  • [33] Determinants of Homocysteine Levels in Colorectal and Breast Cancer Patients
    Ferroni, P.
    Palmirotta, R.
    Martini, F.
    Riondino, S.
    Savonarola, A.
    Spila, A.
    Ciatti, F.
    Sini, V.
    Mariotti, S.
    Del Monte, G.
    Roselli, M.
    Guadagni, F.
    ANTICANCER RESEARCH, 2009, 29 (10) : 4131 - 4138
  • [34] Determinants of homocysteine levels in colorectal and breast cancer patients
    Ferroni, P.
    Palmirotta, R.
    Martini, F.
    Ludovici, G.
    Magnapera, A.
    Rossi, L.
    Vergati, M.
    Formica, V.
    Roselli, M.
    Guadagni, F.
    THROMBOSIS RESEARCH, 2007, 120 : S146 - S146
  • [35] DETERMINANTS OF HOMOCYSTEINE LEVELS IN COLORECTAL AND BREAST CANCER PATIENTS
    Ferroni, P.
    Palmirotta, R.
    Martini, F.
    Ciatti, F.
    Riondino, S.
    Magnapera, A.
    Sini, V.
    Mariotti, S.
    Del Monte, G.
    Roselli, M.
    Guadagni, F.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3281 - 3281
  • [36] Clinical implications of lipid peroxides levels in plasma and tumor tissue in breast cancer patients
    Scandolara, Thalita Basso
    da Silva, Janaina Carla
    Alves, Fernanda Mara
    Malanowski, Jessica
    de Oliveira, Stefania Tagliari
    Maito, Vitor Teixeira
    Rech, Daniel
    Panis, Carolina
    Bonvicino, Cibele
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2022, 161
  • [37] Tumor progression marker for breast cancer - survivin gene (BIRC5)
    Shlyakhtunou, Y.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S104 - S105
  • [38] Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
    Ng, E. K. O.
    Chong, W. W. S.
    Jin, H.
    Lam, E. K. Y.
    Shin, V. Y.
    Yu, J.
    Poon, T. C. W.
    Ng, S. S. M.
    Sung, J. J. Y.
    GUT, 2009, 58 (10) : 1375 - 1381
  • [39] Differential Expression of MicroRNAs in Plasma of Colorectal Cancer Patients: A Potential Marker for Colorectal Cancer Screening
    Sung, Joseph J.
    Chong, Wai Sing
    Jin, Hongchuan
    Lam, Emily K. Y.
    Shin, Vivian Y.
    Yu, Jun
    Poon, Terence C. W.
    Ng, Simon S.
    Ng, Enders K. O.
    GASTROENTEROLOGY, 2009, 136 (05) : A165 - A165
  • [40] Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment
    Shafat, Itay
    Ben Baraky, Ayelet
    Postovskyy, Sergey
    Elhasidy, Ronit
    Ilan, Neta
    Vlodavsky, Israel
    Ben Arush, Miriam Weyl
    NEOPLASIA, 2007, 9 (11): : 909 - 916
12345